FDA Warns Companies Making Unauthorized Diabetes Claims For Their Products

The U.S. Food and Drug Administration issued warning letters to companies that make diabetes-related claims for their products. Part of the FDA’s probe into health benefits claims on products, websites, and other marketing literature, the warning letters covered products ranging from nutritional supplements to topical creams. Neuliven Health, Inc. received a warning letter for claims the company has made for its Glucocil product, including lowering fasting blood sugar levels by up to 29 percent and lowering A1c levels significantly. Also, the FDA warned PharmaTerra, Inc. for claims related to its ProBeta product, which tend to establish that the product is a drug.